T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Amylyx Pharmaceuticals
AMLX
$2.5B
| $181K | ﹤0.01% |
55,600
| – | – |
|
2677
Chegg
CHGG
$89.3M
| $180K | ﹤0.01% |
101,197
+28,300
| +39% | +$69.3K |
|
|
STER
2678
DELISTED
Sterling Check Corp. Common Stock
STER
| $180K | ﹤0.01% |
10,748
+181
| +2% | +$2.87K |
|
2679
Real Brokerage
REAX
$523M
| $179K | ﹤0.01% |
32,160
+1,776
| +6% | +$10.1K |
|
2680
Rayonier Advanced Materials
RYAM
$570M
| $179K | ﹤0.01% |
20,830
+412
| +2% | +$2.85K |
|
|
ESPR
2681
DELISTED
Esperion Therapeutics
ESPR
| $178K | ﹤0.01% |
107,492
| – | – |
|
2682
Farmers National Banc Corp
FMNB
$970M
| $178K | ﹤0.01% |
11,729
+178
| +2% | +$2.58K |
|
2683
TTEC Holdings
TTEC
$77.4M
| $178K | ﹤0.01% |
30,170
+1,251
| +4% | +$6.82K |
|
2684
Ardagh Metal Packaging
AMBP
$3.16B
| $177K | ﹤0.01% |
46,859
+782
| +2% | +$2.76K |
|
|
LAZR
2685
DELISTED
Luminar Technologies
LAZR
| $177K | ﹤0.01% |
13,060
| – | – |
|
2686
NextDecade
NEXT
$1.8B
| $177K | ﹤0.01% |
37,437
+645
| +2% | +$3.9K |
|
2687
SGHC Ltd
SGHC
$6.65B
| $177K | ﹤0.01% |
48,621
+813
| +2% | +$2.8K |
|
2688
RPC Inc
RES
$1.39B
| $176K | ﹤0.01% |
27,564
+570
| +2% | +$3.59K |
|
2689
Accuray
ARAY
$32.9M
| $175K | ﹤0.01% |
97,146
+6,000
| +7% | +$11.4K |
|
|
SELF
2690
Global Self Storage
SELF
$58.9M
| $175K | ﹤0.01% |
33,399
| – | – |
|
2691
Unisys
UIS
$210M
| $175K | ﹤0.01% |
30,739
| – | – |
|
|
DEC
2692
Diversified Energy Company
DEC
$1B
| $174K | ﹤0.01% |
15,231
+256
| +2% | +$3.44K |
|
2693
Evolv Technologies
EVLV
$1.04B
| $173K | ﹤0.01% |
42,477
+693
| +2% | +$2.42K |
|
2694
1-800-Flowers.com
FLWS
$261M
| $173K | ﹤0.01% |
21,712
-86,790
| -80% | -$772K |
|
2695
Teekay
TK
$1.06B
| $171K | ﹤0.01% |
18,577
+421
| +2% | +$3.5K |
|
|
TPIC
2696
DELISTED
TPI Composites
TPIC
| $171K | ﹤0.01% |
37,404
+3,057
| +9% | +$12.5K |
|
2697
Cadiz
CDZI
$295M
| $169K | ﹤0.01% |
55,714
+409
| +0.7% | +$1.33K |
|
2698
Akebia Therapeutics
AKBA
$241M
| $168K | ﹤0.01% |
126,648
| – | – |
|
2699
McEwen Inc
MUX
$1.14B
| $167K | ﹤0.01% |
17,900
| – | – |
|
2700
Pagaya Technologies
PGY
$1.79B
| $167K | ﹤0.01% |
15,779
+2,900
| +23% | +$38.1K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.